Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.30.2 (
endonuclease
)
18,621
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Through the molecular cloning of DNA, cells were obtained that could produce a 300-fold increased level of deoxyuridine triphosphatase (dUTPase). First, lambda pyrE-dut phages were constructed from restriction
endonuclease
fragments. They contained a segment of Escherichia coli DNA that spanned the structural genes for dUTPase (dut) and
orotidylate pyrophosphorylase
(pyrE). The initial isolates demonstrated poor enzyme production and impaired growth. Improved enzyme yields were then obtained from large-plaque derivatives and from mutants with partial deletions of the cloned DNA. The deletion mutants were isolated after the induction of a recombinant prophage whose DNA was too large to be packaged. Finally, a 3.3-kb segment of DNA, containing the dut gene, was transferred to plasmid vectors. The recombinants and their levels of dUTPase overproduction (relative to that of wild type cells) were as follows: a thermoinducible lambda pyrE-dut phage, 45-fold (10-fold for
orotidylate pyrophosphorylase
); a dut-ColE1 type plasmid, 15-fold; and a thermoinducible dut-lambda-ColE1 chimera, 14-fold before induction and 300-fold after induction.
...
PMID:Cloning of the dut (deoxyuridine triphosphatase) gene of Escherichia coli. 610 20